Skip to search.
 BSE Down 1.57% NSE Down 1.66%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.09 Up 0.00(4.92%) 1 Sep 1:30am
Add to Portfolio
Prev Close:0.09
Open:0.09
Bid:0.09 x 20000
Ask:0.09 x 36000
1y Target Est:1.23
Beta:1.64658
Next Earnings Date:N/A
Day's Range:0.09 - 0.09
52wk Range:0.08 - 1.54
Volume:15,955,656
Avg Vol (3m):6,683,890
Market Cap:16.31M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AEZS at this time.

Comparison

Symbol% ChgMkt Cap
AEZSUp 4.92%16.31M
CELGDown 4.80%93.35B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):55.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.31
Quarterly EPS Est (Sep-15) :-0.06
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback